Abstral fentanyl is a Sublingual Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Sentynl Therapeutics, Inc.. The primary component is Fentanyl Citrate.
Product ID | 42358-300_463c068d-9e51-43c7-8d01-116947effb42 |
NDC | 42358-300 |
Product Type | Human Prescription Drug |
Proprietary Name | Abstral fentanyl |
Generic Name | Fentanyl Citrate |
Dosage Form | Tablet, Orally Disintegrating |
Route of Administration | SUBLINGUAL |
Marketing Start Date | 2016-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022510 |
Labeler Name | Sentynl Therapeutics, Inc. |
Substance Name | FENTANYL CITRATE |
Active Ingredient Strength | 300 ug/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022510 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-10-01 |
Marketing End Date | 2019-10-30 |
Ingredient | Strength |
---|---|
FENTANYL CITRATE | 300 ug/1 |
SPL SET ID: | e60f00e9-2cf4-4c20-b570-1c2ea426c8c7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
42358-300 | Abstral fentanyl | Abstral fentanyl |
42358-100 | Abstral fentanyl | Abstral fentanyl |
42358-400 | Abstral fentanyl | Abstral fentanyl |
42358-800 | Abstral fentanyl | Abstral fentanyl |
42358-200 | Abstral fentanyl | Abstral fentanyl |
42358-600 | Abstral fentanyl | Abstral fentanyl |
0093-7865 | Fentanyl Citrate | Fentanyl Citrate |
0093-7866 | Fentanyl Citrate | Fentanyl Citrate |
0093-7867 | Fentanyl Citrate | Fentanyl Citrate |
0093-7868 | Fentanyl Citrate | Fentanyl Citrate |
0093-7869 | Fentanyl Citrate | Fentanyl Citrate |
0093-7870 | Fentanyl Citrate | Fentanyl Citrate |
0406-9202 | FENTANYL CITRATE | FENTANYL CITRATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ABSTRAL 77117021 3563010 Live/Registered |
SENTYNL THERAPEUTICS, INC. 2007-02-27 |